Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -60.00% vs -51.61% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 50.00% vs -30.77% in Mar 2024
Compare Balance Sheet Results of Omkar Pharmachem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.08
4.56
5.52
121.05%
Share Warrants & Outstandings
Total Reserve
-0.65
10.72
-11.37
-106.06%
Shareholder's Funds
9.43
15.28
-5.85
-38.29%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.10
-0.10
-100.00%
Secured Loans
0.00
0.10
-0.10
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.03
0.42
-0.45
-107.14%
Other Long Term Liabilities
0.00
0.08
-0.08
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.12
-0.12
-100.00%
Total Non-Current Liabilities
-0.03
0.72
-0.75
-104.17%
Current Liabilities
Trade Payables
0.01
10.98
-10.97
-99.91%
Other Current Liabilities
0.04
0.16
-0.12
-75.00%
Short Term Borrowings
0.12
2.37
-2.25
-94.94%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.17
13.50
-13.33
-98.74%
Total Liabilities
9.57
29.50
-19.93
-67.56%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.03
10.83
-10.80
-99.72%
Less: Accumulated Depreciation
0.03
6.68
-6.65
-99.55%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.01
4.16
-4.15
-99.76%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
9.30
0.04
9.26
23,150.00%
Long Term Loans & Advances
0.00
0.34
-0.34
-100.00%
Other Non Current Assets
0.00
0.92
-0.92
-100.00%
Total Non-Current Assets
9.31
5.46
3.85
70.51%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
9.41
-9.41
-100.00%
Sundry Debtors
0.10
9.49
-9.39
-98.95%
Cash and Bank
0.11
4.41
-4.30
-97.51%
Other Current Assets
0.06
0.01
0.05
500.00%
Short Term Loans and Advances
0.00
0.72
-0.72
-100.00%
Total Current Assets
0.27
24.04
-23.77
-98.88%
Net Current Assets (Including Current Investments)
0.10
10.54
-10.44
-99.05%
Total Current Assets Excluding Current Investments
0.27
24.04
-23.77
-98.88%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.57
29.50
-19.93
-67.56%
Contingent Liabilities
0.00
0.94
-0.94
-100.00%
Total Debt
0.12
2.47
-2.35
-95.14%
Book Value per share (adjusted)
9.36
15.65
-6.29
-40.19%
Annual - Borrowings
Borrowings 0.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -60.00% vs -51.61% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.01 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
Investments 9.30 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 0.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 50.00% vs -30.77% in Mar 2024






